BUSCOPAN

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Finland, Hong Kong, Croatia, Ireland, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom

Active ingredients

The drug BUSCOPAN contains one active pharmaceutical ingredient (API):

1 Butylscopolamine UNII 0GH9JX37C8 - BUTYLSCOPOLAMINE BROMIDE

Butylscopolamine is an antispasmodic agent which relaxes smooth muscle of the organs of the abdominal and pelvic cavities. It is believed to act predominantly on the intramural parasympathetic ganglia of these organs. Read about Butylscopolamine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BUSCOPAN Coated tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
BUSCOPAN Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A03BB01	Butylscopolamine	A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03B BELLADONNA AND DERIVATIVES, PLAIN → A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
Discover more medicines within A03BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 3473T, 4279F, 5317W
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 504500802135317, 504517110021003, 540921040046817, 540921040046917, 540921040047017
Country: CA	Health Products and Food Branch	Identifier(s): 00363812, 00363839
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00161996, 00162004, 01834598, 02350388, 02544566, 03176975, 03176981, 03203117, 03203123, 03323100, 03517212, 04955032, 04955049, 11134962
Country: EE	Ravimiamet	Identifier(s): 1091630, 1107267, 1415618, 1471430, 1638019, 1755738, 1764817, 1785977, 1792245
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 058164
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 170010, 196925, 236742, 23870, 32428, 379153, 89842
Country: HK	Department of Health Drug Office	Identifier(s): 02712, 02721
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-500455738
Country: IE	Health Products Regulatory Authority	Identifier(s): 15709, 15717
Country: JP	医薬品医療機器総合機構	Identifier(s): 1242002F1330, 1242401A1315
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1015410, 1015411, 1090544
Country: MT	Medicines Authority	Identifier(s): AA1470/00202, MA1470/00201, PI1438/04701A, PI908/00801B
Country: NL	Z-Index G-Standaard	Identifier(s): 13620320
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 2186, 4227, 4243
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17547, 2120, 2121
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100012017, 100255843, 100256624, 100292614, 100298054, 100350040, 100355154, 100363828, 100371437, 100450734
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68439001, W68439002
Country: SG	Health Sciences Authority	Identifier(s): 03574P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9003251B, 9003251BH, 9003252AH, 9003252B, 9003253AH, 9003253B, 9003254H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683060090048, 8683060090055, 8683060090062, 8683060120011, 8683060120028, 8683060750065